InsiderDirector

Michael A Mussallem Insider Trading Activity

Every SEC Form 4 transaction reported by Michael A Mussallem, sourced directly from SEC EDGAR and updated as new filings are accepted.

By · Insider-trading data from SEC EDGAR
Latest filing:

Compiled automatically from SEC EDGAR Form 4 filings and refreshed daily. Figures count purchases (code P) and sales (code S) only — not grants, option exercises, or gifts. How this page is built. Not investment advice.

Quick Answer

Is Michael A Mussallem buying or selling?

Michael A Mussallem reported 0 open-market buys ($0) and 77 sells ($297.9M) across 77 Form 4 filings at 1 company — a net selling position of $297.9M.

Source: SEC EDGAR Form 4

What stands out

  • All 77 of Michael A Mussallem's Form 4 filings are for one company, Edwards Lifesciences Corp (EW).
  • The most recent Form 4 was accepted on May 2, 2024 (2 years ago).
  • No open-market purchases or sales were reported in the last 12 months.

Key Statistics (as of May 2, 2024)

Total Form 4 filings
77
SEC EDGAR
Companies
1
Buys (0)
$0
Sells (77)
$297.9M

Insider sentiment

Net selling

Net insider flow of $297.9M in net selling, filed between Jan 8, 2018 – May 2, 2024.

Companies Michael A Mussallem files for

#CompanyForm 4 filings
1EWEdwards Lifesciences Corp77

Recent Michael A Mussallem transactions

DateTickerRoleTypeSharesValueFiling
May 2, 2024EWDirectorSale29.4K$2.5MSEC ↗
Apr 4, 2024EWDirectorSale29.4K$2.7MSEC ↗
Mar 5, 2024EWDirectorSale29.4K$2.5MSEC ↗
Feb 5, 2024EWDirectorSale29.4K$2.6MSEC ↗
Jan 6, 2024EWDirectorSale29.4K$2.1MSEC ↗
Dec 14, 2023EWDirectorSale29.4K$2.2MSEC ↗
Nov 6, 2023EWDirectorSale29.4K$2.0MSEC ↗
Oct 2, 2023EWDirectorSale29.4K$2.0MSEC ↗
Sep 5, 2023EWDirectorSale29.4K$2.2MSEC ↗
Aug 7, 2023EWDirectorSale29.4K$2.3MSEC ↗
Jul 6, 2023EWDirectorSale29.4K$2.7MSEC ↗
Jun 2, 2023EWDirectorSale29.4K$2.5MSEC ↗
May 11, 2023EWChairman & CEOSale19.9K$1.8MSEC ↗
Apr 17, 2023EWChairman & CEOSale19.9K$1.7MSEC ↗
Mar 15, 2023EWChairman & CEOSale19.9K$1.5MSEC ↗
Feb 15, 2023EWChairman & CEOSale19.9K$1.5MSEC ↗
Jan 13, 2023EWChairman & CEOSale19.9K$1.6MSEC ↗
Dec 14, 2022EWChairman & CEOSale19.9K$1.5MSEC ↗
Nov 15, 2022EWChairman & CEOSale19.9K$1.5MSEC ↗
Oct 14, 2022EWChairman & CEOSale19.9K$1.6MSEC ↗
Sep 22, 2022EWChairman & CEOSale19.9K$1.7MSEC ↗
Aug 15, 2022EWChairman & CEOSale19.9K$2.1MSEC ↗
Jun 14, 2022EWChairman & CEOSale19.9K$1.7MSEC ↗
May 11, 2022EWChairman & CEOSale32.5K$3.1MSEC ↗
Apr 29, 2022EWChairman & CEOSale32.5K$3.5MSEC ↗

Showing the 25 most recent filings of 77. Screen every filing.

Michael A Mussallem insider trading FAQ

Is Michael A Mussallem buying or selling?

Across 77 SEC Form 4 filings, Michael A Mussallem reported 0 open-market purchases totaling $0 and 77 sales totaling $297.9M — a net selling position of $297.9M.

Which companies does Michael A Mussallem file Form 4s for?

Michael A Mussallem has reported insider transactions at 1 company, most often Edwards Lifesciences Corp (EW).

How far back does Michael A Mussallem's filing history go?

Trabud holds Michael A Mussallem's SEC Form 4 filings from Jan 8, 2018 – May 2, 2024, sourced directly from SEC EDGAR.

Where does Trabud get Michael A Mussallem's insider trading data?

Directly from SEC EDGAR Form 4 filings. Every transaction on this page is a real filing accepted by the SEC, updated as new filings arrive.

Related Content

Learn

What is SEC Form 4?

The filing behind every transaction here

Guide

How to Track Insider Trading

A practical workflow for following Form 4 activity

Use Case

Insider Buying Signals

How investors read insider purchases

Track Michael A Mussallem and every other insider

Screen all SEC Form 4 filings by insider, company, transaction value, and role — or ask Trabud's AI agent in plain English.

Open the screener